enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Weight Loss Injections: What You Need to Know, From ... - AOL

   www.aol.com/lifestyle/weight-loss-injections...

   Here’s what to keep in mind about type 2 diabetes medications used to support weight loss and weight loss injections: Weight loss injections are safe and effective when used as prescribed .

3. ECA stack - Wikipedia

   en.wikipedia.org/wiki/ECA_stack

   The effects of the ECA stack on weight loss are primarily due to the ephedrine component. Ephedrine acts both as an α and β adrenergic agonist , stimulating the release of norepinephrine . [ 8 ] Increased circulating norepinephrine in the body then acts on brown adipose tissue and skeletal muscle [ 9 ] by increasing cyclic adenosine ...

4. TrimSpa - Wikipedia

   en.wikipedia.org/wiki/TRIMSPA

   TrimSpa was a dietary supplement designed for weight loss, marketed by the company Goen Technologies and headed by Alexander Szynalski. [1] The ephedra-based supplement was marketed by TrimSpa to help "stave off hunger", [2] until ephedra was banned from the United States. TrimSpa's parent company, Goen Technologies, filed for bankruptcy ...

5. US obesity rates drop for 1st time in a decade, with possible ...

   www.aol.com/us-obesity-rates-drop-1st-160026522.html

   For the first time in over a decade, obesity rates in the United States may finally be heading in the right direction and new weight loss drugs like semaglutide could be part of the reason why. A ...

6. Ephedra (plant) - Wikipedia

   en.wikipedia.org/wiki/Ephedra_(plant)

   The Ephedra alkaloids, ephedrine and pseudoephedrine – constituents of E. sinica and other members of the genus – have sympathomimetic and decongestant qualities, [21] and have been used as dietary supplements, mainly for weight loss. [22] The drug ephedrine is used to prevent low blood pressure during spinal anesthesia. [21]

7. US FDA warns online vendors selling unapproved weight-loss drugs

   www.aol.com/us-fda-warns-online-vendors...

   The letters were issued to Xcel Peptides, Swisschems, Summit Research and Prime Peptides last week after the U.S. health regulator conducted a review of their respective websites in October. The ...